Home / Street Sector / Investment That Totally Worth It: Genworth Financial, Inc. (NYSE:GNW), Manulife Financial Corporation (NYSE:MFC)

Investment That Totally Worth It: Genworth Financial, Inc. (NYSE:GNW), Manulife Financial Corporation (NYSE:MFC)

Genworth Financial, Inc. (NYSE:GNW) kept active in under and overvalue discussion, GNW holds price to book ratio of 0.17 that presents much better indicator to find market price of a share price over its book value of equity for investment valuation.

Fundament/ News Factor in Focus

Taking look on ratio analysis, GNW has forward price to earnings ratio of 5.52. The co is presenting price to cash flow as 0.74 and while calculating price to free cash flow it concluded at 1.19, the low single digit may indicate stock is undervalued and vise versa. On other hand, keeping in mind stable cash flows but few growth prospects make traders to value lower.

The firm has price volatility of 5.18% for a week and 4.91% for a month. Its beta stands at 2.42 times. Narrow down four to firm performance, its weekly performance was 25.74% and monthly performance was 83.21%.

Manulife Financial Corporation (NYSE:MFC) runs in leading trade, it an ascending 1.60% to traded at $13.98. MFC attains analyst recommendation of 1.80 on scale of 1-5 with week’s performance of 4.02%.

To find out the technical position of MFC, it holds price to book ratio of 0.92 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. It has forward price to earnings ratio of 6.85, and price to earnings ratio calculated as 14.32. The price to earnings growth ration calculated as 1.46. MFC is presenting price to cash flow of 1.70 and free cash flow concluded as 3.45.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -41.50%, and looking further price to next year’s EPS is 15.44%. While take a short look on price to sales ratio, that was 0.59 and price to earning ration of 14.32 attracting passive investors.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Analysts Forecasting Profitability Indicators: CSX Corporation (NASDAQ:CSX), Chico’s FAS, Inc. (NYSE:CHS)

CSX Corporation (NASDAQ:CSX) presented as an active mover, shares increasing -2.68% to traded at $37.07 …

Leave a Reply

Your email address will not be published. Required fields are marked *